{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T23:11:17Z","timestamp":1770333077845,"version":"3.49.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.contraception.2010.03.008","type":"journal-article","created":{"date-parts":[[2010,4,14]],"date-time":"2010-04-14T08:26:12Z","timestamp":1271233572000},"page":"119-124","source":"Crossref","is-referenced-by-count":5,"title":["Joseph W. Goldzieher and the birth of hormonal contraception"],"prefix":"10.1016","volume":"82","author":[{"given":"Giuseppe","family":"Benagiano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2010.03.008_bib1","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1001\/jama.230.3.421","article-title":"How the oral contraceptives came to be developed","volume":"230","author":"Goldzieher","year":"1974","journal-title":"J Am Med Ass"},{"key":"10.1016\/j.contraception.2010.03.008_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0022-4731(79)90271-1","article-title":"Gregory Pincus and steroidal contraception: a new departure in the history of mankind","volume":"11","author":"Diczfalusy","year":"1979","journal-title":"J Steroid Biochem"},{"key":"10.1016\/j.contraception.2010.03.008_bib3","first-page":"1","article-title":"Twenty years of oral contraception","volume":"15","author":"Rice-Wray","year":"1981","journal-title":"IPPF Med Bull"},{"key":"10.1016\/j.contraception.2010.03.008_bib4","series-title":"The endocrine glands","author":"Goldzieher","year":"1939"},{"key":"10.1016\/j.contraception.2010.03.008_bib5","series-title":"The adrenal gland in health and disease","author":"Goldzieher","year":"1948"},{"key":"10.1016\/j.contraception.2010.03.008_bib6","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1210\/jcem-16-2-249","article-title":"Treatment of excessive growth in the adolescent female","volume":"16","author":"Goldzieher","year":"1956","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2010.03.008_bib7","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1001\/jama.1949.82900490003007a","article-title":"Toxic effects of percutaneously absorbed steroids","volume":"140","author":"Goldzieher","year":"1949","journal-title":"JAMA"},{"key":"10.1016\/j.contraception.2010.03.008_bib8","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.contraception.2008.02.020","article-title":"Oral contraceptives and individual variability of circulating levels of ethinyl estradiol and progestins","volume":"78","author":"Goldzieher","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.03.008_bib9","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/oxfordjournals.aje.a121082","article-title":"Thromboembolism and oral contraceptives: an epidemiologic case\/control study","volume":"90","author":"Sartwell","year":"1969","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.contraception.2010.03.008_bib10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0010-7824(99)00120-1","article-title":"Bust without boom","volume":"61","author":"Goldzieher","year":"2000","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.03.008_bib11","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0010-7824(95)00222-7","article-title":"Oral contraceptive side effects: where's the beef?","volume":"52","author":"Goldzieher","year":"1995","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.03.008_bib12","first-page":"165","article-title":"Estrogens in oral contraceptives: historical perspectives","volume":"150","author":"Goldzieher","year":"1982","journal-title":"Johns Hopkins Med J"},{"key":"10.1016\/j.contraception.2010.03.008_bib13","series-title":"Improving access to quality care in family planning: medical eligibility criteria for contraceptive use","author":"World Health Organization","year":"2004"},{"key":"10.1016\/j.contraception.2010.03.008_bib14","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/BF02999351","article-title":"Metabolic abnormalities in obesity: a statistical survey","volume":"12","author":"Goldzieher","year":"1945","journal-title":"Am J Dig Dis"},{"key":"10.1016\/j.contraception.2010.03.008_bib15","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1001\/jama.1946.02870190027007","article-title":"Treatment of headache with intravenous sodium nicotinate","volume":"131","author":"Goldzieher","year":"1946","journal-title":"JAMA"},{"key":"10.1016\/j.contraception.2010.03.008_bib16","first-page":"251","article-title":"A new colorimetric method for the determination of pregnanediol","volume":"33","author":"Goldzieher","year":"1948","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.contraception.2010.03.008_bib17","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1210\/jcem-12-2-143","article-title":"Identification of estrogen in the human testis","volume":"12","author":"Goldzieher","year":"1952","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2010.03.008_bib18","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0003-9861(60)90141-7","article-title":"Methylation of 2-hydroxyestradiol-17\u03b2 to 2-methoxyestrone in the human","volume":"87","author":"Axelrod","year":"1960","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.contraception.2010.03.008_bib19","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1210\/jcem-20-2-238","article-title":"The metabolism of 17\u03b1-hydroxyprogesterone and its relation to congenital adrenal hyperplasia","volume":"20","author":"Axelrod","year":"1960","journal-title":"J Clin Endrocrinol Metab"},{"key":"10.1016\/j.contraception.2010.03.008_bib20","first-page":"196","article-title":"Non utilization of mevalonic acid in steroidogenesis by testis tissue","volume":"19","author":"Savard","year":"1960","journal-title":"Fed Proc"},{"issue":"Suppl 28","key":"10.1016\/j.contraception.2010.03.008_bib21","first-page":"175","article-title":"Some effects of progesterone and related compounds upon reproduction and early development in mammals. Proc. 5th Internat Conf Planned Parenthood, Tokyo","volume":"20","author":"Pincus","year":"1956","journal-title":"Acta Endocrin (Khb)"},{"key":"10.1016\/j.contraception.2010.03.008_bib22","first-page":"513","article-title":"Fertility control with long-acting injectable steroids: a preliminary report","volume":"28","author":"Za\u00f1artu","year":"1966","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2010.03.008_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0010-7824(82)90014-2","article-title":"Task force on long-acting injectable contraceptives. Multinational comparative clinical trial of long-acting injectable contraceptives: norethisterone enantathe given in two dosage regimens and depot-medroxyprogesterone acetate. A preliminary report","volume":"25","author":"World Health Organization","year":"1982","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.03.008_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0010-7824(83)80002-X","article-title":"Task force on long-acting injectable contraceptives. Multinational comparative clinical trial of long-acting injectable contraceptives: norethisterone enantathe given in two dosage regimens and depot-medroxyprogesterone acetate. Final report","volume":"28","author":"World Health Organization","year":"1983","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.03.008_bib25","series-title":"Conference on Research in Family Planning, New York, 1960","first-page":"351","article-title":"A field trial with a physiological method of conception control","author":"Goldzieher","year":"1962"},{"key":"10.1016\/j.contraception.2010.03.008_bib26","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1001\/jama.1962.03050180005002","article-title":"Study of norethindrone in contraception","volume":"180","author":"Goldzieher","year":"1962","journal-title":"JAMA"},{"key":"10.1016\/j.contraception.2010.03.008_bib27","first-page":"371","article-title":"Clinical evaluation of contraceptives: a great responsibility","author":"Goldzieher","year":"1965","journal-title":"Yearbook Gynecol"},{"key":"10.1016\/j.contraception.2010.03.008_bib28","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1016\/S0002-9378(16)35793-3","article-title":"Fertility following termination of contraception with norethindrone. Endometrial morphology and conception rate","volume":"84","author":"Goldzieher","year":"1962","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2010.03.008_bib29","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0002-9378(16)39658-2","article-title":"Dysmenorrhea and ovulation. Correlation of the effect of estrogen therapy on pain, the endometrium and the basal body temperature","volume":"54","author":"Haus","year":"1947","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2010.03.008_bib30","series-title":"Program Endocrine Soc, 46th Meeting San Francisco. Chevy Chase (MD): The Endocrine Society","first-page":"68","article-title":"Comparative antiovulatory potency of certain natural and synthetic estrogens","author":"Martinez-Manatou","year":"1964"},{"key":"10.1016\/j.contraception.2010.03.008_bib31","first-page":"625","article-title":"Inhibition of ovulation by estrogens","volume":"122","author":"Gual","year":"1967","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2010.03.008_bib32","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0015-0282(16)36840-6","article-title":"Large-scale study of an oral contraceptive","volume":"19","author":"Hines","year":"1968","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2010.03.008_bib33","first-page":"399","article-title":"Seven years of clinical experience with a sequential oral contraceptive","volume":"13","author":"Goldzieher","year":"1968","journal-title":"Int J Fertil"},{"key":"10.1016\/j.contraception.2010.03.008_bib34","first-page":"200","article-title":"Adenocarcinoma of the endometrium in women taking sequential oral contraceptives","volume":"47","author":"Kelley","year":"1976","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2010.03.008_bib35","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/0002-9378(75)90060-5","article-title":"Comparative studies of the ethynyl estrogens used in oral contraceptives. I. Endometrial response","volume":"122","author":"Goldzieher","year":"1975","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2010.03.008_bib36","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/0002-9378(75)90061-7","article-title":"Comparative studies of the ethynyl estrogens used in oral contraceptives. II. Antiovulatory potency","volume":"122","author":"Goldzieher","year":"1975","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2010.03.008_bib37","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/0002-9378(75)90062-9","article-title":"Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins","volume":"122","author":"Goldzieher","year":"1975","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2010.03.008_bib38","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1016\/0002-9378(90)90550-Q","article-title":"Pharmacokinetics of ethinyl estradiol and mestranol","volume":"163","author":"Goldzieher","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2010.03.008_bib39","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/S0002-9378(89)80010-9","article-title":"Pharmacology of contraceptive steroids: a brief review","volume":"160","author":"Goldzieher","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2010.03.008_bib40","series-title":"Pharmacology of the contraceptive steroids","first-page":"127","article-title":"Pharmacokinetics and metabolism of ethinyl estrogens","author":"Goldzieher","year":"1994"},{"key":"10.1016\/j.contraception.2010.03.008_bib41","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0010-7824(89)90092-9","article-title":"Pharmacokinetics of three bioequivalent norethindrone\/mestranol-50 micrograms and three norethindrone\/ethinyl estradiol-35 micrograms OC formulations: are \u201clow-dose\u201d pills really lower?","volume":"40","author":"Brody","year":"1989","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.03.008_bib42","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0002-9378(16)35484-9","article-title":"Comparison of the endometrial activity of 3 synthetic progestins used in fertility control","volume":"85","author":"Maqueo","year":"1963","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2010.03.008_bib43","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/0002-9378(63)90550-7","article-title":"Comparison of the long-term endometrial effects of synthetic progestins used in fertility control","volume":"87","author":"Rice-Wray","year":"1963","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2010.03.008_bib44","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/0003-9861(61)90189-8","article-title":"Enzymic inadequacies of human polycystic ovaries","volume":"95","author":"Axelrod","year":"1961","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.contraception.2010.03.008_bib45","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0889-8529(18)30236-6","article-title":"Selected aspects of polycystic ovarian disease","volume":"21","author":"Goldzieher","year":"1992","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.contraception.2010.03.008_bib46","series-title":"Advances in Obstet Gynecol","first-page":"159","article-title":"Menopause \u2014 a deficiency disease","author":"Goldzieher","year":"1994"},{"key":"10.1016\/j.contraception.2010.03.008_bib47","doi-asserted-by":"crossref","first-page":"339","DOI":"10.4158\/EP.2.5.339","article-title":"Menopause: a major challenge for endocrinologists","volume":"2","author":"Goldzieher","year":"1996","journal-title":"Endocr Pract"},{"key":"10.1016\/j.contraception.2010.03.008_bib48","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1001\/jama.284.6.691","article-title":"Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk","volume":"284","author":"Schairer","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.contraception.2010.03.008_bib49","first-page":"12","article-title":"Media scan. Hormone replacement therapy and breast cancer risk","volume":"11","author":"Goldzieher","year":"2000","journal-title":"Contracept Rep"},{"key":"10.1016\/j.contraception.2010.03.008_bib50","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA."},{"key":"10.1016\/j.contraception.2010.03.008_bib51","first-page":"1","article-title":"Critique of the report from the Writing Group of the WHI","volume":"10","author":"Goodman","year":"2003","journal-title":"Menopausal Med"},{"key":"10.1016\/j.contraception.2010.03.008_bib52","first-page":"e023","article-title":"A critique of Women's Health Initiative studies (2002\u20132006)","volume":"4","author":"Clark","year":"2006","journal-title":"Nucl Recept Signal"},{"key":"10.1016\/j.contraception.2010.03.008_bib53","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0015-0282(02)04403-5","article-title":"The randomized world is not without its imperfections: reflections on the Women's Health Initiative study","volume":"78","author":"McDonough","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2010.03.008_bib54","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/S0015-0282(03)00376-5","article-title":"Heroic years. Letter to the editor","volume":"79","author":"Goldzieher","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2010.03.008_bib55","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/S0015-0282(03)00377-7","article-title":"Commentary","volume":"79","author":"McDonough","year":"2003","journal-title":"Fertil Steril"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782410000983?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782410000983?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T08:40:57Z","timestamp":1559032857000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782410000983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S0010782410000983"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2010.03.008","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}